Eterna Therapeutics
ERNA
#11171
Rank
ยฃ1.75 M
Marketcap
ยฃ1.04
Share price
-16.56%
Change (1 day)
-2.14%
Change (1 year)

Earnings for Eterna Therapeutics (ERNA)

Earnings in 2026 (TTM): -ยฃ12.37 Million

According to Eterna Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -ยฃ10.78 Million, an increase over its 2024 earnings that were of -ยฃ28.97 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eterna Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ12.37 Million14.7%
2025 -ยฃ10.78 Million-62.78%
2024 -ยฃ28.97 Million84.63%
2023 -ยฃ15.69 Million-16.24%
2022 -ยฃ18.73 Million-80.08%
2021 -ยฃ94.01 Million1596.7%
2020 -ยฃ5.55 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
ยฃ5.95 B-47,243.04%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-ยฃ0.15 Billion 1,031.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
ยฃ12.21 M-196.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-ยฃ14.56 Million 15.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
-ยฃ2.96 Million-76.61%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
ยฃ0.93 B-7,509.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
ยฃ0.19 B-1,615.19%๐Ÿ‡บ๐Ÿ‡ธ USA